Where we are in treat to target era? Predictive factors for remission and drug switching in patients with axial spondyloarthritis: a real-life evidence from BioStaR nationwide registry

dc.date.accessioned	2023-03-06T07:33:30Z
dc.date.available	2023-03-06T07:33:30Z
dc.date.issued	2022
dc.identifier.citation	Clin Rheumatol. 2022 Jul;41(7):2053-2063. doi: 10.1007/s10067-022-06145-8. Epub 2022 Mar 30.
dc.identifier.uri	https://hdl.handle.net/20.500.12619/100650
dc.relation.isversionof	10.1007/s10067-022-06145-8
dc.relation.isversionof	10.1007/s10067-022-06145-8
dc.title	Where we are in treat to target era? Predictive factors for remission and drug switching in patients with axial spondyloarthritis: a real-life evidence from BioStaR nationwide registry
dc.relation.journal	Clin Rheumatol
dc.identifier.doi	10.1007/s10067-022-06145-8
dc.contributor.author	Bodur H
dc.contributor.author	Bodur H
dc.contributor.author	Yurdakul FG
dc.contributor.author	Ataman S
dc.contributor.author	Cay HF
dc.contributor.author	Gurer G
dc.contributor.author	Capkin E
dc.contributor.author	Sezer İ